|Minimum Order Quantity||50 Page|
|Work Location||Across The Globe|
|Service Duration||3 days|
|Start Date / Month||as per demand|
|Translation Editing And Proofreading||yes|
Translation is required at many stages in the course of bringing a drug to market, including clinical research, regulatory submissions, manufacturing, marketing and packaging. While the direct cost of translation is very small, translation can have a surprisingly large effect—for better and for worse—on several crucial factors. These factors include the total cost of the trials, the time to market, the possibility of lawsuits or rejection by regulators and even the safety and efficacy of the marketed product.
For instance, regulators sometimes reject applications or delay their approval if the required translations are inadequate. As a result, cost can increase dramatically, and market entry can be delayed by months if not years, with loss of competitiveness.
Moreover, inadequate translation can mask crucial links between the data from research sites which operate in different languages. Such “lost” links might have alerted the sponsor that the compound tested is a “blockbuster” or, alternatively, a poison. Thus, inadequate translation can have enormously high indirect costs. The loss of data quality cannot be compensated by improving another part of the development process.